When Ozempic and other GLP-1 medications entered  the mainstream conversation around weight loss, many medspas quickly began offering semaglutide and tirzepatide treatments, and the regulatory landscape changed just as fast. Increased scrutiny around prescribing, sourcing, and advertising makes the category far from a straightforward service expansion. 

For medspa operators, staying competitive means deciding which trends are worth expanding into, and whether the business can realistically support new operations and compliance requirements. The question isn’t whether or not patients want GLP-1 medspa services—they do. It’s whether your medspa has the right clinical oversight, compliant workflows, and operational systems to support them. 

This guide walks through what medspas should evaluate before launching GLP-1 services, along with how Boulevard supports the day-to-day infrastructure behind medspa weight loss programs. 

What Are GLP-1 Weight Loss Services? 

GLP-1 weight loss services are medically supervised programs that use prescription medications like semaglutide or tirzepatide to support weight management. In medspas, these programs often include eligibility screenings, medical oversight, and broader lifestyle guidance, and sit alongside complementary aesthetic treatments. 

The medications themselves are called GLP-1 receptor agonists. This class of drugs mimics glucagon-like peptide 1 (GLP-1), a hormone produced in the small intestine that helps the body regulate blood sugar, appetite, and digestion. While GLP-1 receptor agonists were initially developed as a type 2 diabetes treatment, they’re commonly used in weight management programs to increase satiety and slow digestion, which lowers most patients’ overall food intake and encourages weight loss.

In medspas, GLP-1 receptor agonists are typically offered in physician-supervised weight loss programs via injections. Medspas can naturally pair these programs with other aesthetic services, like skin rejuvenation or sculpting treatments, to address decreased facial volume and looser skin. A semaglutide medspa program may look similar to other multi-treatment services, but is operationally more complicated, as it involves uniquely regulated prescription medications and sourcing compliance.

Semaglutide vs. Tirzepatide

Semaglutide and tirzepatide are the two most common medications used in medical spa weight loss programs. Both are injections given with strict medical oversight, but there are some differences between them:

• Semaglutide: Semaglutide is the GLP-1 receptor agonist behind brand names like Ozempic and Wegovy. Medspa semaglutide programs may be easier for patients to recognize because of the broader public conversation around Ozempic.

• Tirzepatide: Tirzepatide mimics two different hormones—GLP-1 and gastric inhibitory polypeptide (GIP), which can reduce the severity of GI side effects common in GLP-1s. It’s known more commonly by brand names Mounjaro and Zepbound.

Branded vs. Compounded GLP-1s: The 2026 Sourcing Landscape

When demand for GLP-1 weight loss medications suddenly spiked in 2023, supply initially struggled to keep up. Semaglutide and tirzepatide both went through FDA-recognized shortages, and during that period, some medical providers met patient demand through compounded versions: the same medication formulated by licensed pharmacists, physicians, and outsourcing facilities rather than manufactured as FDA-approved branded products.

Branded products like Ozempic and Wegovy have gone through FDA reviews for safety, effectiveness, and quality. Compounded drugs are prepared under specific federal and state compounding rules, but the FDA does not review compounded drugs before they reach patients.

Throughout 2025 and 2026, the FDA resolved semaglutide and tirzepatide shortages and changed how medical providers could use compounded GLP-1 medications. Today, medspa operators need to weigh their options between possible sourcing paths:

• Branded Prescriptions: Patients can receive FDA-approved branded GLP-1 products through a licensed prescriber and pharmacy. A medspa Ozempic offering should only be described as Ozempic if patients receive the branded medication, not compounded semaglutide. 

• 503A Patient-Sourcing Compounding: 503A pharmacies are state-licensed pharmacies that prepare compounded medications for specific patients. Compounded medications are typically prescribed when a patient’s medical needs cannot be met by an FDA-approved drug, often to avoid ingredients that may trigger an allergy or other adverse reaction. During FDA-recognized shortages, some compounded GLP-1s had greater availability, but that option narrowed once semaglutide and tirzepatide came off the shortage list. Under the current FDA framework, medspas should not treat 503A compounding as a broad replacement for branded GLP-1 products within a weight loss program.

• 503B Outsourcing Facility Supply: 503B outsourcing facilities are allowed to compound large drug batches sold directly to healthcare facilities. They operate under a different federal framework than 503A pharmacies and are subject to additional FDA requirements around bulk batching. 503B can generally compound bulk drug substances only if the substance appears on the 503B bulk list or if the drug appears on FDA’s drug shortage list. Currently, semaglutide and tirzepatide are not on either list.
  

Before designing and advertising GLP-1 services, medspa operators need to carefully review their medication source, prescribing model, and existing or potential relationships to nearby pharmacies. Any review should happen with a qualified healthcare attorney and the relevant state pharmacy board to confirm compliance with all federal and state requirements before offering GLP-1 medication.

Compliance Requirements for Medspas Offering GLP-1 Services

Like most other medical spa services, GLP-1 programs have many moving parts. Before adding them to your service menu, you need to understand how prescription medications, patient screening, and ongoing clinical decisions align with federal and local compliance requirements.

Use the areas below as a starting point for conversations with a healthcare attorney and your state medical and pharmacy boards.

Medical Director Oversight

GLP-1 services involve prescription medication and ongoing patient monitoring that fit into strict medical oversight structures. Check your local legislation to see if your region requires written protocols, delegated-task supervision, and/or adverse-event escalation procedures for GLP-1 services.

Helpful questions to ask: 

• What level of physician or licensed prescriber oversight does our state require for GLP-1 weight loss services? 

• Which parts of a GLP-1 weight loss program must be reviewed or approved by a medical director? 

• How do adverse events, medication changes, and follow-up visits need to be charted?

State Licensing and Scope of Practice

Rules around evaluating patients, administering injections, and monitoring patient follow-up vary from state to state. Medspa operators should verify each practitioner's role before launching a program, especially if nurses and other licensed staff will be helping out.

Helpful questions to ask: 

• Who’s legally allowed to evaluate patients, prescribe GLP-1 medications, and monitor progress in our state?

• On our current team, who can administer GLP-1 injections? Will we need to hire a new practitioner for this role?

Marketing and Advertising Restrictions

GLP-1 marketing comes under heavy scrutiny to protect prospective patients. Medical spas need to be careful about how they describe prescription services alongside effective wellness offerings. Before going live, every website page, social media post, and booking description post needs to be extensively reviewed for weight loss claims and brand-name references that could open your medspa up to legal problems.

Helpful questions to ask: 

• How can we refer to branded products like Ozempic and Zepbound?

• What marketing claims are we allowed to make about GLP-1 weight loss results? 

• Does our state require specific disclosures when advertising prescription weight loss services? 

Payment Processing Considerations

GLP-1 services may need a payment-processing review before launch. Many major medspa payment processors place additional restrictions on (or just don’t process) prescription medication sales because of the pharmaceutical industry’s strict regulations. Before launching a GLP-1 program, confirm that your processor supports payments for these services, and make a backup plan for accepting payments if necessary.

Helpful questions to ask: 

• Does our payment processor support payments for prescription weight loss services? 

• Are recurring GLP-1 memberships or packages allowed under our current agreement? 

• What documentation do we need for refunds, disputes, and chargebacks? 

How to Structure a GLP-1 Program at Your Medspa

After all your compliance efforts are in place, the next question is how GLP-1 services fit into your day-to-day operations. That means planning clinical handoffs, packaging details, and complimentary services. Like all the other parts of this service, you should review the final structure with a healthcare attorney and relevant state medical and pharmacy boards before the program goes live.

Staffing and Clinical Workflows

GLP-1 programs move patients through a long, recurring care path where they frequently interact with MDs, NPs, and front desk staff. Handoffs need to be airtight as they move from initial eligibility consultations to recurring treatments. This ensures that patients speak with the right person under the applicable medical spa regulations and staff always have current information about individual treatment plans.

Depending on state rules and the provider model, a medical director may oversee eligibility, prescribing, and follow-up, while licensed nurses support visits or injections. Front desk staff also need to understand how GLP-1 scheduling and billing should be handled, since there are additional steps they’ll need to take. 

Each role should be reviewed with counsel or the appropriate state boards to ensure staff understands the extent of their responsibilities. That might include which questions need to go back to the medical director, who’s responsible for updating patient records, and how notes need to be captured and safeguarded under HIPAA.

Patient Intake and Documentation

Injectables and ongoing treatment require detailed intake and documentation processes. Before treatment begins, providers may need to collect medical history, current medications, and consent forms, among other information required by the provider model or state regulations. 

That documentation needs to stay organized in a safe and secure place. As patients move through the program, treatment records will need to reflect dosages, missed visits, and provider follow-up. The goal is to keep each visit connected to the larger treatment plan without scattering important details across different forms and charts. 

Boulevard’s medical spa software supports the operational side of intake with fully customizable intake forms and treatment records, which let medical spas build best practices around their GLP-1 workflows.

Service Packaging and Memberships

GLP-1 programs are naturally suited to membership and package models since they have a recurring cadence, including weekly or biweekly injections and monthly check-ins. Rather than scheduling each visit as a standalone appointment, medspas can create structures that support patient consistency and predictable revenue. 

Operators should still review billing terms, cancellation policies, and refund rules to ensure clear communication, especially if the membership program includes recurring payments. 

Companion Aesthetic Services

It’s common for patients to seek aesthetic treatment as their weight changes. Rapid weight loss can contribute to changes in facial volume and skin laxity. These concerns are common in conversations around GLP-1 medications, especially since terms like “Ozempic face” have entered the mainstream. 

Medical spas are already positioned for many complimentary services, since they tend to also offer injectables, body contouring, and skin treatments. For operators, it’s an opportunity to think about GLP-1 services as part of a broader patient experience rather than a standalone weight loss offering.

How Boulevard Supports Medspa Weight Loss Programs 

A GLP-1 program can fall apart fast if patients have to call every week or staff have to manually track individual program schedules. Boulevard’s medical spa software can manage medspa GLP-1 programs with self-booking tools that let patients schedule within the availability, timing, and service rules that your medical spa sets. 

That booking experience sits inside Boulevard’s all-in-one platform designed specifically for medical spa workflows, so recurring appointments stay connected to the rest of the patient experience. Instead of managing booking, communication, and memberships in separate tools, everything lives in one place. 

See how Boulevard supports medical spa weight loss programs with a demo. 

FAQ

What Type of Professional Liability Coverage Should Medspas Review Before Offering GLP-1 Programs?

Medical spas should review their existing malpractice policies and professional liability coverage. Coverage varies by carrier and state, so this should be confirmed before a program goes live. And standard policies may not automatically cover clinical weight management treatments, so ask your insurance providers whether GLP-1 services are included or require additional coverage.

Can Medspas Ship GLP-1 Medications Directly to a Patient’s Home?

It depends on the medication source, dispensing model, and state pharmacy dispensing rules. Medical spas shouldn’t offer direct-to-patient shipping unless they can confirm that the dispensing model is allowed where they operate. If you opt to ship GLP-1 medications, you should also verify handling requirements with your supplier, since GLP-1s require temperature-controlled storage and shipping.

How Should Medspas Price Their GLP-1 Weight Loss Programs?

Medspa pricing for GLP-1 programs range from $300 to $1,500 for branded medication programs. The enormous variation depends on several factors, including the source, dosing protocols, and how the package bundles other services. Operators should benchmark against their local market and build pricing around the full patient experience rather than the injection alone. 

How Do Medspas Retain GLP-1 Patients After Their Weight Loss Program Ends?

GLP-1 patients often seek additional aesthetic services after they reach their weight loss goals. As their bodies change, it’s common to inquire about facial volume loss, skin laxity, and body contouring, which are service areas that already exist for some medspas. 

Letting patients know about their options early can build trust, since they’ll know what to expect and understand which aesthetic options may be available through your medspa later. As patients move through the process, early conversations can make the transition into ongoing care feel more natural rather than opportunistic upsells.

How Does Boulevard Help Medspas Manage the Operational Complexity of a GLP-1 Program?

GLP-1 programs come with extra administrative work because patients need detailed intake and treatment records, recurring appointments, and membership management. Boulevard brings all those workflows into a single platform design for medical spas, so front desk staff and providers aren’t toggling between disconnected tools to stay on track. That makes it easier to manage the operational side of a recurring weight loss program while facilitating a smoother patient experience.